4.5 Article

Elevated hydroxycholesterols in Norwegian patients with hereditary spastic paraplegia SPG5

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Clinical characteristics of Taiwanese patients with Hereditary spastic paraplegia type 5

Cheng-Ta Chou et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Review Clinical Neurology

Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches

Samuel Shribman et al.

LANCET NEUROLOGY (2019)

Article Medicine, Research & Experimental

mRNA as a Novel Treatment Strategy for Hereditary Spastic Paraplegia Type 5

Stefan Hauser et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)

Article Biochemistry & Molecular Biology

ClinVar: improving access to variant interpretations and supporting evidence

Melissa J. Landrum et al.

NUCLEIC ACIDS RESEARCH (2018)

Letter Clinical Neurology

SPG5 siblings with different phenotypes showing reduction of 27-hydroxycholesterol after simvastatin-ezetimibe treatment

Andrea Mignarri et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Article Clinical Neurology

Electrophysiological characterisation in hereditary spastic paraplegia type 5

Fiore Manganelli et al.

CLINICAL NEUROPHYSIOLOGY (2011)

Article Pharmacology & Pharmacy

Functional Characterization of CYP2B6 Allelic Variants in Demethylation of Antimalarial Artemether

Masashi Honda et al.

DRUG METABOLISM AND DISPOSITION (2011)

Article Biochemistry & Molecular Biology

Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis

Rebecca Schuele et al.

JOURNAL OF LIPID RESEARCH (2010)

Article Genetics & Heredity

Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration

Maria K. Tsaousidou et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2008)

Review Critical Care Medicine

Predictive value of somatosensory evoked potentials for awakening from coma

LR Robinson et al.

CRITICAL CARE MEDICINE (2003)